- Home
- CERS vs MHN Comparison
CERS vs MHN Comparison
Compare CERS & MHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- MHN
- Stock Information
- Founded
- CERS 1991
- MHN 1997
- Country
- CERS United States
- MHN United States
- Employees
- CERS N/A
- MHN N/A
- Industry
- CERS EDP Services
- MHN Investment Bankers/Brokers/Service
- Sector
- CERS Technology
- MHN Finance
- Exchange
- CERS Nasdaq
- MHN Nasdaq
- Market Cap
- CERS 324.3M
- MHN 334.2M
- IPO Year
- CERS 1997
- MHN N/A
- Fundamental
- Price
- CERS $1.70
- MHN $10.62
- Analyst Decision
- CERS Buy
- MHN
- Analyst Count
- CERS 3
- MHN 0
- Target Price
- CERS $3.17
- MHN N/A
- AVG Volume (30 Days)
- CERS 1.9M
- MHN 59.2K
- Earning Date
- CERS 10-30-2024
- MHN 01-01-0001
- Dividend Yield
- CERS N/A
- MHN 4.17%
- EPS Growth
- CERS N/A
- MHN N/A
- EPS
- CERS N/A
- MHN N/A
- Revenue
- CERS $176,229,000.00
- MHN N/A
- Revenue This Year
- CERS $26.47
- MHN N/A
- Revenue Next Year
- CERS $11.48
- MHN N/A
- P/E Ratio
- CERS N/A
- MHN N/A
- Revenue Growth
- CERS 14.71
- MHN N/A
- 52 Week Low
- CERS $1.38
- MHN $8.69
- 52 Week High
- CERS $2.59
- MHN $10.81
- Technical
- Relative Strength Index (RSI)
- CERS 46.20
- MHN 42.20
- Support Level
- CERS $1.63
- MHN $10.69
- Resistance Level
- CERS $2.03
- MHN $10.79
- Average True Range (ATR)
- CERS 0.11
- MHN 0.09
- MACD
- CERS -0.01
- MHN 0.00
- Stochastic Oscillator
- CERS 31.37
- MHN 12.50
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About MHN Blackrock MuniHoldings New York Quality Fund Inc.
BLACKROCK MUNIHOLDINGS NEW YORK QUALITY FUND, INC. is a closed-ended management investment company. The fund's investment objective is to provide shareholders with current income exempt from federal income tax and New York State and New York City personal income taxes.